Results 211 to 220 of about 76,806 (261)
Some of the next articles are maybe not open access.
2003
It is estimated that 56,200 new cases of non-Hodgkin’ s lymphoma (NHL) were diagnosed in the United States in 2001, and approx 26,300 people died from NHL, which makes it the fifth leading cause of cancer death in men and the sixth leading cause of cancer death among women (1).
Igor Espinoza-Delgado, Dan L. Longo
openaire +1 more source
It is estimated that 56,200 new cases of non-Hodgkin’ s lymphoma (NHL) were diagnosed in the United States in 2001, and approx 26,300 people died from NHL, which makes it the fifth leading cause of cancer death in men and the sixth leading cause of cancer death among women (1).
Igor Espinoza-Delgado, Dan L. Longo
openaire +1 more source
Nursing Standard, 2016
Essential facts Non-Hodgkin's lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. The disease has many subtypes, with two main broad categories: high-grade or aggressive and low-grade or ...
openaire +2 more sources
Essential facts Non-Hodgkin's lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. The disease has many subtypes, with two main broad categories: high-grade or aggressive and low-grade or ...
openaire +2 more sources
Medicine, 2000
Abstract Non-Hodgkin's lymphoma (NHL) is a heterogeneous group of malignant diseases characterized by replacement of normal lymphoid structure by diffuse and nodular collections of abnormal lymphocytes.
Claire Dearden, Estella Matutes
openaire +1 more source
Abstract Non-Hodgkin's lymphoma (NHL) is a heterogeneous group of malignant diseases characterized by replacement of normal lymphoid structure by diffuse and nodular collections of abnormal lymphocytes.
Claire Dearden, Estella Matutes
openaire +1 more source
The Lymphomas: Hodgkin's Disease and Non-Hodgkin's Lymphomas
American Pharmacy, 1991This review presents an overview of a heterogeneous group of disorders that fall under the general heading of lymphomas. Many specific subtypes and presentations exist; their presentations, treatments, and prognoses vary greatly. Patients with lymphomas are generally treated with external beam radiation therapy, chemotherapy, or a combination of these ...
openaire +2 more sources
The Lancet, 2003
Non-Hodgkin lymphoma is a non-specific term that includes several lymphoproliferative malignant diseases with different clinical and histological appearances. Here, we concentrate on adult lymphomas. We look at their molecular basis, at the development of a classification system based on a better understanding of the biology of the various subgroups ...
Linda S, Evans, Barry W, Hancock
openaire +2 more sources
Non-Hodgkin lymphoma is a non-specific term that includes several lymphoproliferative malignant diseases with different clinical and histological appearances. Here, we concentrate on adult lymphomas. We look at their molecular basis, at the development of a classification system based on a better understanding of the biology of the various subgroups ...
Linda S, Evans, Barry W, Hancock
openaire +2 more sources
Medical Clinics of North America, 1984
The non-Hodgkin's lymphomas, although sharing a common origin, often present physicians with wide variations in natural history and prognosis. The proper therapy of these diseases is based on an understanding of these differences and upon the information gained by pathologic review and staging, as well as the available chemotherapeutic and ...
openaire +2 more sources
The non-Hodgkin's lymphomas, although sharing a common origin, often present physicians with wide variations in natural history and prognosis. The proper therapy of these diseases is based on an understanding of these differences and upon the information gained by pathologic review and staging, as well as the available chemotherapeutic and ...
openaire +2 more sources
Pediatric non-Hodgkin lymphoma
Current Hematologic Malignancy Reports, 2007Non-Hodgkin's lymphoma (NHL) accounts for 7% of cancer in children and adolescents in the United States, or approximately 1000 cases annually. NHL in the pediatric population differs from that observed in adult patients with respect to staging systems, histologic subtypes of disease, treatment, and outcomes.
Thomas G, Gross, Amanda M, Termuhlen
openaire +3 more sources
Current Opinion in Hematology, 1996
Attention is being directed at increasing the intensity of therapy as a means of improving the results of primary therapy for non-Hodgkin's lymphoma. There is increasing evidence that the use of high-dose consolidation therapy followed by autologous hematopoietic rescue in first remission improves survival in high-risk patients.
P J, Bierman, J O, Armitage
openaire +2 more sources
Attention is being directed at increasing the intensity of therapy as a means of improving the results of primary therapy for non-Hodgkin's lymphoma. There is increasing evidence that the use of high-dose consolidation therapy followed by autologous hematopoietic rescue in first remission improves survival in high-risk patients.
P J, Bierman, J O, Armitage
openaire +2 more sources
Pediatric Annals, 1988
The non-Hodgkin's lymphomas are a group of diseases for which substantial progress has been made in understanding tumor biology and effectiveness of treatment during the last few years. These advances may provide insight into the development of neoplasms because of recognized association of lymphomas with viral infections and immunodeficiency.
openaire +2 more sources
The non-Hodgkin's lymphomas are a group of diseases for which substantial progress has been made in understanding tumor biology and effectiveness of treatment during the last few years. These advances may provide insight into the development of neoplasms because of recognized association of lymphomas with viral infections and immunodeficiency.
openaire +2 more sources
Benzene and non-Hodgkin's lymphoma
The Journal of Pathology, 1999Incidence rates for non-Hodgkin's lymphoma (NHL) have been rising throughout the world for several decades, and no convincing explanation exists for the majority of this increase. The commonest subtypes of NHL have no well-defined aetiological factors but lymphoma development has been linked with exposure to a variety of chemicals, including nitrates ...
S R, O'Connor, P B, Farmer, I, Lauder
openaire +2 more sources